Sorafenib plus hepatic arterial infusion chemotherapy with oxaliplatin versus sorafenib alone for advanced hepatocellular carcinoma

OBJECTIVE: To compare the efficacy of sorafenib plus hepatic arterial infusion chemotherapy (HAIC) with oxaliplatin to that of sorafenib alone in patients with advanced hepatocellular carcinoma (HCC). METHODS: This was a retrospective, single-center trial. Between April 3, 2017 and July 2, 2018, 104...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Yang, Lai, JiaYing, Liang, RunBin, He, MinKe, Shi, Ming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: KeAi Publishing 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8562173/
https://www.ncbi.nlm.nih.gov/pubmed/34805877
http://dx.doi.org/10.1016/j.jimed.2019.07.005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8562173/
https://www.ncbi.nlm.nih.gov/pubmed/34805877
http://dx.doi.org/10.1016/j.jimed.2019.07.005

Ejemplares similares